Skip to main content
. 2014 Jan 24;15(Suppl 1):S6. doi: 10.1186/1471-2164-15-S1-S6

Table 2.

An exploration of KEGG cancer pathways.

Two data sets Three data sets
KEGG cancer pathways U/D CES Diff. FDR CES Diff. FDR
PPAR signaling * down 0.671 >0.1 0.194 0.563 >0.1 0.210
MAPK signaling ** down 0.639 >0.1 0.209 0.857 >0.1 0.063
ERBB signaling * up 0.629 >0.1 0.119 0.581 >0.1 0.188
Calcium signaling ** down 0.925 >0.1 0.051 0.694 >0.1 0.153
Cytokine-cytokine receptor interaction *** down 0.717 >0.1 0.172 0.943 >0.1 0.022
Cell cycle *** up 0.998 >0.1 <0.001 0.959 >0.1 0.012
p53 signaling *** up 0.999 >0.1 <0.001 0.944 >0.1 0.018
MTOR signaling * down 0.724 >0.1 0.167 0.611 >0.1 0.193
Apoptosis * down 0.1 0.776 >0.1 0.102
WNT signaling *** down 0.1 0.888 >0.1 0.048
TGF-β signaling down 0.1 0.521 >0.1 0.236
VEGF signaling *** down 0.784 >0.1 0.136 0.919 >0.1 0.033
Focal adhesion *** up >0.999 >0.1 <0.001 0.830 >0.1 0.077
ECM receptor interaction *** up 0.996 >0.1 <0.001 0.977 >0.1 0.005
Adherens junction * up 0.646 >0.1 0.114 0.1
JAK-STAT signaling *** down 0.875 >0.1 0.082 0.901 >0.1 0.044

Our application results for sixteen KEGG cancer pathways. "Diff" column presents the absolute difference between the CES based on up-regulated differential expression and the CES based on down-regulated differential expression. If "Diff" 0.1, then no further analysis results is presented. Otherwise, the larger CES as well as the related FDR and differential expression direction (up or down) are presented in the "CES", "FDR" and "U/D" columns, respectively. Both application results (an integrative analysis of two data sets and an integrative analysis of three data sets) are presented for the listed pathways. Pathways with symbols *, ** or *** means that FDRs < 0.2, FDRs < 0.1 or FDRs < 0.05 are observed for at least one applications, respectively.